These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7199324)

  • 1. Excretion and metabolism of 14C-midazolam in humans following oral dosing.
    Heizmann P; Ziegler WH
    Arzneimittelforschung; 1981; 31(12a):2220-3. PubMed ID: 7199324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of an anxiolytic imidazobenzodiazepine by the dog.
    Kolis SJ; Postma EJ; Williams TH; Sasso GJ; Schwartz MA
    Drug Metab Dispos; 1983; 11(4):324-8. PubMed ID: 6137338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of midazolam after i.v. administration (author's transl)].
    Amrein R; Cano JP; Eckert M; Coassolo P
    Arzneimittelforschung; 1981; 31(12a):2202-5. PubMed ID: 7199322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.
    Hilbert J; Pramanik B; Symchowicz S; Zampaglione N
    Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination and pharmacokinetics of midazolam and its hydroxymetabolites in plasma and urine of man and dog by means of high-performance liquid chromatography.
    Vree TB; Baars AM; Booij LH; Driessen JJ
    Arzneimittelforschung; 1981; 31(12a):2215-9. PubMed ID: 7199323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood level, excretion, and metabolite pattern of [14C]-brotizolam in humans.
    Bechtel WD; van Wayjen RG; van den Ende A
    Arzneimittelforschung; 1986 Mar; 36(3A):575-8. PubMed ID: 3718580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of nicardipine hydrochloride in healthy male volunteers.
    Rush WR; Alexander O; Hall DJ; Cairncross L; Dow RJ; Graham DJ
    Xenobiotica; 1986 Apr; 16(4):341-9. PubMed ID: 3716455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic studies of [14C]-flumecinol in humans.
    Klebovich I; Csetényi J; Kerpel-Fronius S; Vereczkey L
    Arzneimittelforschung; 1987 Mar; 37(3):368-71. PubMed ID: 3593454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolic fate of 14C-quazepam in man.
    Zampaglione N; Hilbert JM; Ning J; Chung M; Gural R; Symchowicz S
    Drug Metab Dispos; 1985; 13(1):25-9. PubMed ID: 2858372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
    Cameron BD; Draffan GH; Dunsire JP; Zimmer A
    Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, metabolism, and excretion of [14C]MK-0767 (2-methoxy-5-(2,4-dioxo-5-thiazolidinyl)-N-[[4-(trifluoromethyl)phenyl] methyl]benzamide) in humans.
    Kochansky CJ; Rippley RK; Yan KX; Song H; Wallace MA; Dean D; Jones AN; Lasseter K; Schwartz J; Vincent SH; Franklin RB; Wagner J
    Drug Metab Dispos; 2006 Sep; 34(9):1457-61. PubMed ID: 16772365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of 14C-alpha-cyclodextrin in germ-free and conventional rats.
    Van Ommen B; De Bie AT; Bär A
    Regul Toxicol Pharmacol; 2004 Jun; 39 Suppl 1():57-66. PubMed ID: 15265616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of flumecinol in humans.
    Klebovich I; Vereczkey L; Tóth E; Tamás J; Mák M; Jalsovszky G; Holly S
    Xenobiotica; 1987 Oct; 17(10):1247-58. PubMed ID: 3424871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic fate of 3-(3-methylphenyl)-5-hydroxymethyl-2-oxazolidinone (toloxatone), a new antidepressant agent, in man.
    Malnoë A; Benedetti MS
    Xenobiotica; 1979 May; 9(5):281-8. PubMed ID: 494659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
    Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
    Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.